Shanghai Pharmaceuticals Holding Co., Ltd
601607
Classifica tra le azioni
#2386
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Prezzo delle azioni
$2.43
Capitalizzazione di mercato
$8.09B
Variazione (1 giorno)
-1.16%
Variazione (1 anno)
-5.94%
Paese
CN
Scambia Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Categoria
Healthcare
Rapporto P/B per Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Rapporto P/B al October 2026 TTM: 0.77
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Shanghai Pharmaceuticals Holding Co., Ltd, il rapporto P/B attuale (TTM) è 0.77. Alla fine del 2024, era pari a 1.09.
Storico del rapporto P/B per Shanghai Pharmaceuticals Holding Co., Ltd da 2001 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 0.77 | -11.86% |
| 2025 | 0.87 | -19.60% |
| 2024 | 1.09 | 20.35% |
| 2023 | 0.90 | -2.60% |
| 2022 | 0.93 | -19.06% |
| 2021 | 1.14 | -4.90% |
| 2020 | 1.20 | -4.00% |
| 2019 | 1.25 | 5.43% |
| 2018 | 1.19 | -38.12% |
| 2017 | 1.92 | 15.49% |
| 2016 | 1.66 | -7.02% |
| 2015 | 1.79 | 12.23% |
| 2014 | 1.59 | 4.01% |
| 2013 | 1.53 | 26.50% |
| 2012 | 1.21 | 4.32% |
| 2011 | 1.16 | -75.63% |
| 2010 | 4.76 | -68.69% |
| 2009 | 15.21 | 526.91% |
| 2008 | 2.43 | -51.65% |
| 2007 | 5.02 | 218.23% |
| 2006 | 1.58 | 74.44% |
| 2005 | 0.90 | -19.64% |
| 2004 | 1.13 | -31.51% |
| 2003 | 1.64 | -24.59% |
| 2002 | 2.18 | -5.78% |
| 2001 | 2.31 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| -27.3394 | -3,665.39% |
US
|
|
| - | - |
US
|
|
| -20.2798 | -2,744.73% |
US
|
|
| - | - |
US
|
|
| 6.4701 | 743.78% |
AU
|
